Target intelligence / Profile preview

Cell-Biomaterial Interface (CBI)

Target
CBI
Molecular classification
Other
01

Overview

The cell-biomaterial interface is the dynamic region of interaction between biological systems and synthetic or natural materials (Stevens & George, 2005, Nature Materials). It is characterized by the rapid adsorption of proteins from physiological fluids, which form a provisional matrix that cells recognize via surface receptors like integrins (Lutolf & Hubbell, 2005, Nature Biotechnology). This interface governs how a host organism responds to an implant, influencing critical processes such as cell proliferation, migration, and differentiation through mechanotransduction pathways (Ventre et al., 2012, Journal of the Royal Society Interface). While not a single therapeutic target molecule, it is a focal point for biomaterial design aimed at controlling the foreign body response and ensuring the successful integration of medical devices (Anderson et al., 2008, Seminars in Immunology). Engineering the physical and chemical properties of this interface, such as topography and stiffness, allows for the modulation of immune responses and the promotion of regenerative healing. Understanding these interactions is essential for the development of advanced prosthetics, tissue engineering scaffolds, and biosensors.

Other names
Bio-interfaceCell-substrate interfaceImplant-tissue interfaceCell-matrix interface
02

Mechanism of action

Not applicable as this is a biological interface rather than a single molecular target.

03

Biological functions

Cell adhesionMechanotransductionSignal transductionCell differentiationTissue integration
04

Disease associations

Foreign body responseFibrosisImplant failureInfection (Biofilm formation)Thrombosis
05

Safety considerations

Chronic inflammationFibrous encapsulationThrombosis (for blood-contacting materials)Immune rejectionAseptic loosening
06

Biomarkers

Focal adhesion kinase (FAK) phosphorylation (PubMed: 22438287)Integrin expression levels (Nature Materials, 2005)Vinculin recruitment to focal adhesions (Journal of Cell Science, 2003)RhoA GTPase activity (Journal of the Royal Society Interface, 2012)

Beyond the preview

Go deeper on Cell-Biomaterial Interface (CBI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-Biomaterial Interface (CBI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call